聖農發展(002299.SZ)上修業績預告 2019年度淨利潤預增171.01%-178.98%
格隆匯1月3日丨聖農發展(002299.SZ)發佈業績預告修正公告,之前2019年第三季度報告正文中披露,預計2019年度歸屬於上市公司股東的淨利潤為37.05億元-38.05億元。
修正後,預計2019年度歸屬於上市公司股東的淨利潤40.8億元-42億元,同比增長171.01%-178.98%。
報告期內,白羽肉雞行業供給持續緊張,需求增長勢頭未減,行業雞肉價格整體上升明顯,公司銷售產品價格亦超出先前預期。
報告期內,公司憑藉特有的一體化全產業鏈優勢,在穩定生產的同時,持續挖掘企業自身發展動力,推動經營、管理效率提升,各重要生產指標及成本、費用均有不同程度改進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.